Ashton’s Story Shows Why Pediatric Cancer Research Matters – St. Baldrick’s Foundation
shared a post on LinkedIn:
“Meet Ashton, who serves as a reminder as to why pediatric cancer research matters.
In 2022, at just 6 years old, Ashton was diagnosed with T-cell acute lymphoblastic leukemia – a form of blood cancer.
To access the lifesaving treatment he needed, Ashton and his mom had to relocate nearly two hours from home. Over the next two years, he underwent high-dose chemotherapy—treatments originally designed for adults—that came with side effects: loss of mobility due to neuropathy, frequent hospital stays, and hair loss.
Today, Ashton is in recovery. He’s back at school with his friends, playing with his sisters, and slowly regaining strength. But the impact of cancer treatment lingers. He still faces abdominal pain and receives ongoing monitoring and blood tests to ensure his health remains stable.
Ashton’s resilience is nothing but remarkable. But no child should have to endure treatments this harsh.
That’s why funding research for kinder, more effective treatments is so important.
Join us in fueling more lifesaving childhood cancer research.”
More posts featuring St. Baldrick’s Foundation on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023